# DAWNZERA

NDC: 71860-103
Generic name: donidalorsen
Labeler / Manufacturer: Ionis Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20250821

FDA application: NDA219407

## Active ingredients

- DONIDALORSEN SODIUM: 80 mg/.8mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"71860-103"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=71860-103
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3ff501e0-f75f-07da-e063-6294a90a0cb7